| | | | | | | | | Sponsored | | Upgrade your cobas® 6800/8800 systems to Software 2.0. Experience lightning-fast performance, improved user experience, and intelligent scheduling that eliminates manual sorting. Save time and costs with flexible, customizable QC intervals. Evolve your lab. |
|
|
| | |
| |
| | |
|
|
| | | | | | Join Dr. William E. Winter on November 13 for a free CE webinar exploring the essential role of HbA1c in diagnosing and managing diabetes, including proper testing methodology, potential interferences, interpretation alongside CGM, and alternative glycemic measurements when HbA1c is unreliable. |
|
|
| | The Women’s Initiative for Screening and Health program is looking to award an organization up to $1 million to form a coalition across multiple disciplines to revise the Health Resources and Services Administration-supported Women’s Preventive Services Guidelines, according to an announcement. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Most of what determines how an assay performs is decided before you run your first qPCR reaction, sequence a sample, or build an immunoassay or flow cytometry panel. The Assay Development Handbook covers the pre-analytical decisions that get locked in early and how to make them before they're permanent. |
|
|
| | |
| |
| | |
|
|
| | | | | | Werfen’s ‘Thank You’ campaign celebrates healthcare professionals and laboratory teams whose diagnostic work helps guide life-saving clinical decisions. |
|
|
|
| |
| | |
|
|
| | | | | | Medical Laboratory Observer (MLO) is continuing its series of polls on point-of-care testing (POCT) in clinical laboratories. Tell us: Which area has seen the greatest growth in POCT at your organization? |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Optimize productivity with navify® digital solutions. We simplify workflows to turn lab testing into clear, actionable insights. |
|
|
| | |
| |
| | |
|
|
| | | | Sponsored | | In this QuickChat, Christina Wichmann, Head of Content at MLO, and Tara Crawford Parks, Director of Translational Research and Development at DNA Genotek, will explore the significance of FDA 510(k) clearance for Colli-Pee™•Dx and how it supports patient-centred STI testing through convenient... |
|
|
|
| |
| | |
|
|
| | | | | | Roche announced that it will present new data across its pharmaceuticals and diagnostics portfolios at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) Congress, taking place in Boston, MA, from 16–19 November 2026. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
